| Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis PA Muraro, M Pasquini, HL Atkins, JD Bowen, D Farge, A Fassas, ... Jama neurology 74 (4), 459-469, 2017 | 264 | 2017 |
| Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma LJ Costa, MJ Zhang, X Zhong, A Dispenzieri, S Lonial, A Krishnan, ... Biology of Blood and Marrow Transplantation 19 (11), 1615-1624, 2013 | 127 | 2013 |
| Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma A Saad, A Mahindra, MJ Zhang, X Zhong, LJ Costa, A Dispenzieri, ... Biology of Blood and Marrow Transplantation 20 (3), 402-408. e1, 2014 | 123 | 2014 |
| Salvage second hematopoietic cell transplantation in myeloma LC Michaelis, A Saad, X Zhong, J Le-Rademacher, CO Freytes, DI Marks, ... Biology of Blood and Marrow Transplantation 19 (5), 760-766, 2013 | 121 | 2013 |
| Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation M Alsina, PS Becker, X Zhong, A Adams, P Hari, S Rowley, ... Biology of Blood and Marrow Transplantation 20 (8), 1183-1189, 2014 | 108 | 2014 |
| Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a center for international blood and marrow transplant research … D Weisdorf, M Eapen, A Ruggeri, MJ Zhang, X Zhong, C Brunstein, ... Biology of Blood and Marrow Transplantation 20 (6), 816-822, 2014 | 96 | 2014 |
| Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors DI Marks, KA Woo, X Zhong, FR Appelbaum, V Bachanova, JN Barker, ... Haematologica 99 (2), 322, 2014 | 88 | 2014 |
| Older patients with myeloma derive similar benefit from autologous transplantation M Sharma, MJ Zhang, X Zhong, MH Abidi, G Akpek, U Bacher, ... Biology of Blood and Marrow Transplantation 20 (11), 1796-1803, 2014 | 86 | 2014 |
| Does androgen deprivation therapy protect against severe complications from COVID-19? Patel, Zhong, Liaw, Tremblay, Tsao, Galsky, Oh Annuals of Oncology, 2020 | 84 | 2020 |
| Nonadherence to medications for chronic conditions and nonadherence to adjuvant hormonal therapy in women with breast cancer AI Neugut, X Zhong, JD Wright, M Accordino, J Yang, DL Hershman JAMA oncology 2 (10), 1326-1332, 2016 | 83 | 2016 |
| Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research MC Pasquini, J Voltarelli, HL Atkins, N Hamerschlak, X Zhong, KW Ahn, ... Biology of Blood and Marrow Transplantation 18 (10), 1471-1478, 2012 | 83 | 2012 |
| Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma R Vij, S Kumar, MJ Zhang, X Zhong, J Huang, A Dispenzieri, MH Abidi, ... Biology of Blood and Marrow Transplantation 21 (2), 335-341, 2015 | 79 | 2015 |
| Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy YL Liu, A Saraf, SM Lee, X Zhong, H Hibshoosh, K Kalinsky, EP Connolly Breast cancer research and treatment 157, 555-564, 2016 | 72 | 2016 |
| Second transplants for multiple myeloma relapsing after a previous autotransplant—reduced-intensity allogeneic vs autologous transplantation CO Freytes, DH Vesole, J LeRademacher, X Zhong, RP Gale, RA Kyle, ... Bone marrow transplantation 49 (3), 416-421, 2014 | 67 | 2014 |
| Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL) DL Hershman, LH Kushi, GC Hillyer, E Coromilas, D Buono, L Lamerato, ... Breast cancer research and treatment 157, 133-143, 2016 | 65 | 2016 |
| Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation M Eapen, BR Logan, MM Horowitz, X Zhong, MA Perales, SJ Lee, ... Journal of Clinical Oncology 33 (4), 364, 2015 | 59 | 2015 |
| Multiple Sclerosis–Autologous Hematopoietic Stem Cell Transplantation (MS-AHSCT) Long-term Outcomes Study Group. Long-term outcomes after autologous hematopoietic stem cell … PA Muraro, M Pasquini, HL Atkins, JD Bowen, D Farge, A Fassas, ... JAMA Neurol 74 (4), 459-469, 2017 | 52 | 2017 |
| Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission ED Warlick, K Paulson, R Brazauskas, X Zhong, AM Miller, BM Camitta, ... Biology of Blood and Marrow Transplantation 20 (2), 202-208, 2014 | 42 | 2014 |
| New Cancers after Autotransplantations for Multiple Myeloma A Mahindra, G Raval, P Mehta, R Brazauskas, MJ Zhang, X Zhong, ... Biology of Blood and Marrow Transplantation 21 (4), 738-745, 2015 | 41 | 2015 |
| Bortezomib-based induction for transplant ineligible AL amyloidosis and feasibility of later transplantation RF Cornell, X Zhong, C Arce-Lara, E Atallah, L Blust, WR Drobyski, ... Bone marrow transplantation 50 (7), 914-917, 2015 | 34 | 2015 |
Angela DispenzieriMayo ClinicDirección de correo verificada de mayo.edu
